Clinical trial
Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients…
NCT00084773 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00084773 |
|---|---|
| Title | Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer |
| Official title | A Pilot Clinical Trial of Preoperative Cetuximab With Concurrent Continuous Infusion Fluorouracil and Pelvic Radiation in Patients With Local-Regionally Advanced Rectal Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | cetuximab, fluorouracil, neoadjuvant therapy, radiation therapy |
| Enrollment | 28 |
| Start date | Mar 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Mar 1, 2010 |
| First posted | Jun 11, 2004 |
| Last update posted | Dec 22, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: